Bisphenol A exposure may increase the risk of development of atopic disorders in children

I-Jen Wang1, Chia-Yang Chen2, Carl-Gustaf Bornehag3

  • 1Department of Pediatrics, Taipei Hospital, Ministry of Health and Welfare, Taipei, Taiwan; Institute of Environmental and Occupational Health Sciences, College of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Health Risk Management, China Medical University, Taichung, Taiwan.

Insights

Postnatal exposure to Bisphenol A (BPA) is linked to higher IgE levels and an increased risk of asthma in children, especially girls. This suggests BPA may contribute to the development of allergic diseases.

Area of Science:

  • Environmental Health
  • Pediatric Allergy
  • Toxicology

Background:

  • The impact of Bisphenol A (BPA) exposure on the development of atopic disorders remains largely unknown.
  • Understanding this relationship is crucial for public health, particularly in pediatric populations.

Purpose of the Study:

  • To investigate the association between postnatal Bisphenol A (BPA) exposure and allergic diseases in children.
  • To examine the role of Immunoglobulin E (IgE) levels in the potential pathogenesis of BPA-related allergic diseases.
  • To explore gender-specific differences in these associations.

Main Methods:

  • A cohort of 453 children from Taiwan was studied, collecting urine and blood samples at ages 3 and 6 years.
  • Urinary Bisphenol A glucuronide (BPAG) levels were quantified using UPLC-MS/MS.
  • Multivariate regression and mediation analyses were employed to assess associations between BPAG, IgE levels, and allergic diseases, including asthma.

Main Results:

  • Higher urinary BPAG levels at age 3 correlated positively with IgE levels at age 3 and 6, particularly in girls.
  • BPAG levels at age 3 were significantly associated with an increased risk of asthma at both ages 3 and 6.
  • Mediation analysis indicated that IgE levels account for approximately 70% of the effect of BPA exposure on asthma risk.

Conclusions:

  • Postnatal Bisphenol A (BPA) exposure is associated with elevated IgE levels in children.
  • BPA exposure may elevate the risk of developing allergic diseases, with a more pronounced effect observed in girls.
  • These findings highlight the potential role of BPA as an environmental factor contributing to childhood allergies.
Abstract

Related Concept Videos

Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
132
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
702
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
169
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
461
Allergic Reactions02:06

Allergic Reactions

Overview
33.5K